# Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands

> **NCT07039552** · — · RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 10000 (estimated)

## Conditions studied

- Hereditary Breast and Ovarian Cancer Syndrome
- BRCA Mutations

## Interventions

- **PROCEDURE:** risk-reducing salpingo-oophorectomy (RRSO)

## Key facts

- **NCT ID:** NCT07039552
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-01-01
- **Primary completion:** 2028-12-30
- **Final completion:** 2035-12-30
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07039552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07039552, "Development and Validation of an Ovarian Cancer Risk Prediction Model for Family Members of Ovarian Cancer Probands". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07039552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*